GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular and cellular neurosciences

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mcn.2015.01.001PMID 25616162PMCID PMC4393771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users

  2014cited by this paper
• Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia

  2014cited by this paper
• Eradication of human immunodeficiency virus from brain reservoirs

  2014cited by this paper
• Morphine Enhances HIV-1SF162-Mediated Neuron Death and Delays Recovery of Injured Neurites

  2014cited by this paper
• Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3β signaling in bipolar patients.

  2014cited by this paper
• Regional Variations of Antioxidant Capacity and Oxidative Stress Responses in HIV-1 Transgenic Rats With and Without Methamphetamine Administration

  2013cited by this paper
• GSK-3β: A Bifunctional Role in Cell Death Pathways

  2012influential reference
• Substance abuse increases the risk of neuropathy in an HIV‐infected cohort

  2012cited by this paper
• Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.

  2011cited by this paper
• Neurocognitive Impact of Substance Use in HIV Infection

  2011cited by this paper
• Morphine and gp120 Toxic Interactions in Striatal Neurons are Dependent on HIV-1 Strain

  2011cited by this paper
• Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G

  2011cited by this paper
• Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

  2011cited by this paper
• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts

  2011cited by this paper
• Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death

  2011cited by this paper
• Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?

  2011cited by this paper
• PTEN gene silencing prevents HIV-1 gp120IIIB-induced degeneration of striatal neurons

  2011cited by this paper
• alproate attenuates the development of morphine antinociceptive tolerance

  2010influential reference
• Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis.

  2010cited by this paper
• Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

  2010cited by this paper
• Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.

  2010influential reference
• Toll-like receptor 2 is required for opioids-induced neuronal apoptosis.

  2010cited by this paper
• Morphine Modulation of Thrombospondin Levels in Astrocytes and Its Implications for Neurite Outgrowth and Synapse Formation*

  2010cited by this paper
• Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

  2010influential reference
• Molecular and Therapeutic Potential and Toxicity of Valproic Acid

  2010cited by this paper
• Molecular Pathology of Neuro-AIDS (CNS-HIV)

  2009influential reference
• HIV-related neurocognitive impairment in the HAART era

  2009cited by this paper
• Morphine enhances Tat-induced activation in murine microglia

  2009cited by this paper
• Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

  2009cited by this paper
• Inhibition of EGF‐induced ERK/MAP kinase‐mediated astrocyte proliferation by μ opioids: integration of G protein and β‐arrestin 2‐dependent pathways

  2009cited by this paper
• Cell‐specific actions of HIV‐Tat and morphine on opioid receptor expression in glia

  2008cited by this paper
• The effects of illicit drugs on the HIV infected brain.

  2008cited by this paper
• Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV‐1 tat transgenic mice

  2008cited by this paper
• Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death

  2008influential reference
• HIV and antiretroviral therapy in the brain: neuronal injury and repair

  2008influential reference
• Association of GSK3B with Alzheimer disease and frontotemporal dementia.

  2008cited by this paper
• Activation of cyclin‐dependent kinase 5 by calpains contributes to human immunodeficiency virus‐induced neurotoxicity

  2007cited by this paper
• Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.

  2007cited by this paper
• Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS

  2007cited by this paper
• The prevalence and incidence of neurocognitive impairment in the HAART era

  2007cited by this paper
• Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

  2007cited by this paper
• Neurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs

  2006cited by this paper
• Protecting the Synapse: Evidence for a Rational Strategy to Treat HIV-1 Associated Neurologic Disease

  2006influential reference
• Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.

  2006influential reference
• Effects of Glycogen Synthase Kinase 3β and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats

  2006cited by this paper
• Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

  2006cited by this paper
• Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's Disease

  2006cited by this paper
• Human immunodeficiency virus‐encoded Tat activates glycogen synthase kinase‐3β to antagonize nuclear factor‐κB survival pathway in neurons

  2006influential reference
• Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers

  2005influential reference
• HIV-1 infection and AIDS: consequences for the central nervous system

  2005influential reference
• Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

  2005influential reference
• Neurological complications of HIV infection.

  2005cited by this paper
• Synergistic increases in intracellular Ca2+, and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat

  2005cited by this paper
• The neuropathogenesis of AIDS

  2005influential reference
• Molecular targets of opiate drug abuse in neuro AIDS

  2005cited by this paper
• Neuroprotective Mechanisms of Lithium in Murine Human Immunodeficiency Virus-1 Encephalitis

  2005influential reference
• Evolving paradigms in the pathogenesis of HIV-1-associated dementia

  2005influential reference
• Distinct Biological Properties of Human and Serological

  2004cited by this paper
• HIV dementia: an evolving disease.

  2004cited by this paper
• Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

  2004cited by this paper
• Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures.

  2004influential reference
• Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

  2003cited by this paper
• Human immunodeficiency virus-associated dementia: An evolving disease

  2003influential reference
• Opioid G protein-coupled receptors: signals at the crossroads of inflammation.

  2003cited by this paper
• Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis

  2003influential reference
• Morphine induces apoptosis of human microglia and neurons.

  2002cited by this paper
• Differential effects of mu-opioid receptor ligands on Ca(2+) signaling.

  2002cited by this paper
• Lithium ameliorates HIV-gp120-mediated neurotoxicity.

  2002influential reference
• The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.

  2002cited by this paper
• The GSK3β signaling cascade and neurodegenerative disease

  2002influential reference
• The GSK3 beta signaling cascade and neurodegenerative disease.

  2002influential reference
• HIV and Drug Misuse in the Edinburgh Cohort

  2002cited by this paper
• GSK3 takes centre stage more than 20 years after its discovery.

  2001influential reference
• A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

  2001cited by this paper
• Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

  2000cited by this paper
• HIV dementia: the role of the basal ganglia and dopaminergic systems

  2000influential reference
• Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

  1999influential reference
• Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/ in situ hybridisation technique

  1999cited by this paper
• Transient Increases in Intracellular Calcium Result in Prolonged Site-selective Increases in Tau Phosphorylation through a Glycogen Synthase Kinase 3β-dependent Pathway*

  1999cited by this paper
• Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals.

  1999cited by this paper
• HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated Neurotoxicity

  1999influential reference
• CNS as an HIV-1 reservoir; BBB and drug delivery.

  1999cited by this paper
• Immunomodulatory role of opioids in the central nervous system.

  1998influential reference
• μ-Opioid Receptor Activates Signaling Pathways Implicated in Cell Survival and Translational Control*

  1998influential reference
• Regional, developmental, and cell cycle‐dependent differences in μ, δ, and κ‐opioid receptor expression among cultured mouse astrocytes

  1998cited by this paper
• Neurological complications of HIV infection.

  1998influential reference
• Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.

  1998cited by this paper
• beta-catenin is a target for the ubiquitin-proteasome pathway.

  1997cited by this paper
• β‐catenin is a target for the ubiquitin–proteasome pathway

  1997cited by this paper
• Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders

  1997influential reference
• HIV dementia and the basal ganglia.

  1997influential reference
• Cellular reservoirs of HIV‐1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

  1996cited by this paper
• Localization of HIV‐1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

  1996cited by this paper
• HIV‐1 DNA in brains in AIDS and pre‐AIDS: Correlation with the stage of disease

  1996cited by this paper
• Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications.

  1995cited by this paper
• Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord

  1995influential reference
• The neuropathogenesis of HIV‐1 infection

  1994influential reference

• Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer’s disease-like pathology: modulatory effects of CCR5 antagonists

  2025cites this paper
• Unraveling cervical inflammation in HIV-infected women: The regulatory role of miR-204-5p and miR-3691-3p.

  2025cites this paper
• HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives

  2025cites this paper
• Effect of Kinases in Extracellular Vesicles from HIV-1-Infected Cells on Bystander Cells

  2025cites this paper
• Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders

  2025cites this paper
• Opioids induce constipation by prompting alpha-Synuclein hyperphosphorylation in the colonic myenteric plexus.

  2025cites this paper
• Inhibition of the P38 MAPK/NLRP3 Pathway Mitigates Cognitive Dysfunction and Mood Alterations in Aged Mice after Abdominal Surgery Plus Sevoflurane.

  2024cites this paper
• Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex

  2023cites this paper
• Constitutive expression of HIV-1 viral proteins induces progressive synaptodendritic alterations in medium spiny neurons: implications for substance use disorders

  2023cites this paper
• HIV-associated neurotoxicity and cognitive decline: Therapeutic implications.

  2021cites this paper
• Glycogen synthase kinase‐3 inhibition rescues sex‐dependent contextual fear memory deficit in human immunodeficiency virus‐1 transgenic mice

  2020cites this paper
• HIV and opiates dysregulate K+-Cl- cotransporter 2 (KCC2) to cause GABAergic dysfunction in primary human neurons and Tat-transgenic mice.

  2020cites this paper
• Lithium reverses the effect of opioids on eNOS/nitric oxide pathway in human umbilical vein endothelial cells

  2020cites this paper
• Opioid-Mediated HIV-1 Immunopathogenesis

  2020cites this paper
• The effect of opioid abuse on HIV infected nervous system

  2020cites this paper
• Supraphysiologic‐dose anabolic–androgenic steroid use: A risk factor for dementia?

  2019cites this paper
• Effects of HIV‐1 Tat on oligodendrocyte viability are mediated by CaMKIIβ–GSK3β interactions

  2019cites this paper
• Endogenous Opiates and Behavior: 2016.

  2018cites this paper
• Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats

  2018cites this paper
• The effects of the HIV-1 Tat protein and morphine on the structure and function of the hippocampal CA1 subfield

  2017cites this paper
• SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1–42 into hippocampus of mice

  2017cites this paper
• Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors

  2016cites this paper
• HIV, opiates, and enteric neuron dysfunction

  2015cites this paper
• Effects of HIV-1 viral protein Tat on the viability and function of oligodendroglial cells

  2015cites this paper